Devex: Opinion: Global health innovation is a prescription for European leadership
Cécile Vernant, head of E.U. advocacy for Deutsche Stiftung Weltbevölkerung (DSW)

“…In order to achieve [the Sustainable Development Goals (SDGs)], governments throughout the world need to urgently scale up their investment in global health innovation — developing new vaccines, drugs, and diagnostics that will be key to a 2030 that is free from diseases of poverty. … In 2017, the E.U. is undertaking a midterm review of its seven-year budget, identifying priorities for the next three years for the overall budget and the E.U.’s research program, Horizon2020. The E.U. will also launch discussions for the next multiyear budget cycle, to launch in 2020. These parallel processes provide a critical opportunity for the E.U. to assess what its funding for global health innovation has achieved, where it can be improved, and how much additional investment is needed. Here are three ways that Europe can grasp this opportunity. 1. Meet[ing] its funding targets. … 2. Improving synergies. … 3. Making investment more effective…” (11/7).